A Self-Fulfilling Prophecy: Comparing 177Lu-Psma Radioligand Therapy in Taxane Naïve vs Post-Taxane Metastasized Prostate Cancer Patients?

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.119.228742
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Taxane Chemotherapy for Hormone-Naïve Prostate Cancer With Its Expanding Role as Breakthrough Strategy

Frontiers in Oncology
Cancer ResearchOncology
2016English

Self-Fulfilling Prophecy

English

Early Experience of Rechallenge 177Lu-Psma Radioligand Therapy After an Initial Good Response in Patients With mCRPC

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2014English

OC16.06: Macrosomia: A Self-Fulfilling Prophecy

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Loss of SLCO1B3 Drives Taxane Resistance in Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

565 the Microbial Flora of Taxane Therapy-Associated Nail Disease in Cancer Patients

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy